Wednesday, 19 February 2014

New finding points to potential options for attacking stem cells in triple-negative breast cancer

New research from the University of Michigan Comprehensive Cancer Center and Georgia Regents University finds that a protein that fuels an inflammatory pathway does not turn off in breast cancer, resulting in an increase in cancer stem cells. This provides a potential target for treating triple negative breast cancer, the most aggressive form of the disease. Read more here.

Study mentioned: Kim G, et al. SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model. Oncogene. 2014 Feb 17. [Epub ahead of print] PMID: 24531711

No comments:

Post a Comment